Mode
Text Size
Log in / Sign up

Vitamin D supplementation does not reduce risk of incident tuberculosis infection or diseaseVitamin D Pills Do Not Lower Tuberculosis Risk in Large Trial Review

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that vitamin D supplementation does not reduce the risk of tuberculosis infection or disease.

This individual participant data meta-analysis evaluated the impact of vitamin D supplementation on tuberculosis outcomes in 14,619 participants across multiple randomized trials. The study specifically assessed incident tuberculosis infection and disease as primary outcomes, with secondary focus on mortality and serious adverse events.

The meta-analysis found no significant reduction in incident tuberculosis infection (aOR 0.97; 95% CI 0.81-1.18; p=0.79) or incident tuberculosis disease (aOR 0.78; 95% CI 0.56-1.10; p=0.15). Furthermore, no evidence of effect modification was found in subgroups with 25-hydroxyvitamin D <25 nmol/L, with aORs of 0.95 for infection and 1.01 for disease.

Authors noted that the 95% confidence interval for the prevention of tuberculosis disease remains compatible with a potentially important benefit, suggesting some uncertainty in the magnitude of the effect. Clinically, the data suggests that vitamin D supplementation does not reduce the risk of tuberculosis infection or disease in the studied populations, regardless of baseline vitamin D levels.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the role of vitamin D in preventing tuberculosis. While other evidence indicates that multi-scale computational methods can identify tuberculosis vulnerabilities and predict drug resistance, this study specifically evaluates the prophylactic effect of vitamin D. It does not contradict the finding that host-directed therapy, including metformin and statins, may modulate immune response in tuberculosis patients.

Tuberculosis, or TB, is a serious infection that mainly affects the lungs. Some researchers thought vitamin D might help protect people from TB because it plays a role in the immune system. To test this idea, scientists combined data from many double-blind, placebo-controlled trials, where some people took vitamin D and others took a dummy pill.

The combined analysis included 14,619 participants. For TB infection, measured by skin or blood tests, vitamin D made no meaningful difference: about 9,557 people were studied, and the chance was roughly the same as with placebo. For active TB disease, there was also no clear benefit across 14,533 people. The results stayed the same even for people with very low vitamin D levels at the start.

Serious side effects were not increased by taking vitamin D. The researchers noted one caveat: the range of possible effects for TB disease still leaves room for a meaningful benefit, so a smaller protective effect cannot be ruled out.

Overall, this large review found no evidence that vitamin D supplements prevent TB infection or disease in the groups studied. People should not rely on vitamin D alone to protect against TB.

What this means for you:
Vitamin D supplements did not lower TB infection or disease risk in a large review of over 14,000 people.

Common questions

Does vitamin D help prevent tuberculosis?

In this large pooled analysis of 14,619 people, vitamin D supplements did not reduce the risk of new TB infection or TB disease. The results were similar even in people with very low vitamin D levels. The researchers noted that some benefit for TB disease cannot be fully ruled out, but overall there was no clear protection.

How many people were in this vitamin D and TB analysis?

The analysis included 14,619 participants from double-blind, placebo-controlled randomized trials. The TB infection result was based on 9,557 participants, and the TB disease result was based on 14,533 participants. This is a large body of evidence, which makes the overall finding more reliable than a single small study.

Were there side effects from vitamin D in these trials?

The analysis reported that serious adverse events were not affected by vitamin D. Other safety details, such as minor side effects or dropouts, were not reported in the summary. If you take vitamin D for any reason, talk with your doctor about the right dose and whether it is appropriate for you.

Should I stop taking vitamin D to prevent TB?

This analysis looked at whether vitamin D prevents TB in trial populations, not at individual decisions. It found no clear reduction in TB infection or disease. Whether to take vitamin D depends on your own health and reasons for taking it, so discuss any changes with your doctor rather than stopping or starting on your own.

Study Details

Study typeMeta analysis
Sample sizen = 14,619
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
Background: Several randomised controlled trials of vitamin D supplementation for prevention of tuberculosis infection and disease have been conducted, but no individual participant data (IPD) meta-analysis has been conducted. Methods: We conducted a systematic review, one-stage and two-stage IPD meta-analysis (PROSPERO CRD420251173446) of double-blind, placebo-controlled randomised trials of vitamin D supplementation for prevention of tuberculosis infection or disease. We searched MEDLINE, Embase, Scopus, Cochrane and ClinicalTrials.gov from inception to October 29, 2026. The co-primary outcomes were incident tuberculosis infection (evidenced by tuberculin skin test or Interferon Gamma Release Assay conversion) and incident tuberculosis disease. Mixed-effects models estimated adjusted odds ratios (aORs), accounting for trial and prespecified covariates. Prespecified subgroup analyses investigated effect modification by sex and age, body-mass index, vitamin D status, and BCG vaccination status. Findings: Four trials contributed IPD for 14,619 participants. Vitamin D did not reduce risk of incident tuberculosis infection (9,557 participants; aOR 0.97, 95% CI 0.81-1.18; p=0.79) or incident tuberculosis disease (14,533 participants; aOR 0.78, 95% CI 0.56-1.10; p=0.15). There was no evidence of effect modification by participant characteristics investigated in sub-group analyses, including in participants with 25-hydroxyvitamin D <25 nmol/L (infection: aOR 0.95, 95% CI 0.67-1.34; disease: 1.01, 0.45-2.30). Serious adverse events and mortality were unaffected. Interpretation: Vitamin D supplementation did not reduce the risk of incident tuberculosis infection or disease in the populations studied, either overall or within sub-groups. The 95% confidence interval of the effect estimate for prevention of tuberculosis disease remains compatible with a potentially important benefit, and further trials for this indication may be warranted. Funding: Barts Charity (ref G-002700).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.